SuperworthAbbott Laboratories dividend yield ABT
Dividends per share over the last twelve months divided by the share price, since 1983.
- Today, Oct 23, 2026
- 2.43%
- 10-year median
- 1.8%
- Against its 10-year history
- 93rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 1.2% to 2.9%
- Peer median
- 1.1%
Abbott Laboratories pays 2.43% of its share price in dividends over a year, as of Oct 23, 2026.
That is above its ten-year median of 1.8%, higher than on 93% of days in the last ten years.
Over that time it ranged from 1.2% in Feb 2021 to 2.9% in May 2026.
The median for 7 medical device stocks of a similar size is 1.1%.
Dividend yield over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.4% | 1.9% | 2.9% |
| 2025 | 1.9% | 1.6% | 2.0% |
| 2024 | 1.9% | 1.7% | 2.1% |
| 2023 | 1.9% | 1.7% | 2.2% |
| 2022 | 1.7% | 1.3% | 2.0% |
| 2021 | 1.3% | 1.2% | 1.5% |
| 2020 | 1.3% | 1.3% | 1.9% |
| 2019 | 1.5% | 1.4% | 1.6% |
| 2018 | 1.6% | 1.5% | 1.9% |
| 2017 | 1.9% | 1.9% | 2.6% |
| 2016 | 2.7% | 2.3% | 2.7% |
| 2015 | 2.1% | 1.8% | 2.3% |
| 2014 | 1.9% | 1.4% | 2.2% |
| 2013 | 1.5% | 1.5% | 2.9% |
| 2012 | 3.1% | 2.8% | 3.5% |
| 2011 | 3.4% | 3.4% | 3.9% |
| 2010 | 3.6% | 2.8% | 3.7% |
| 2009 | 2.9% | 2.5% | 3.6% |
| 2008 | 2.7% | 2.2% | 2.8% |
| 2007 | 2.2% | 2.0% | 2.5% |
Against its peers
Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.
| Company | Dividend yield |
|---|---|
| ABTAbbott Laboratories | 2.43% |
| MDTMedtronic | 3.00% |
| SYKStryker | 1.15% |
| BSXBoston Scientific | n/m |
| EWEdwards Lifesciences | n/m |
| GEHCGE HealthCare Technologies | 0.20% |
| DXCMDexCom | n/m |
| ZBHZimmer Biomet | n/m |
| Peer median | 1.15% |
Where Abbott Laboratories ranks
What the dividend yield tells you
Yearly dividends per share divided by the share price.
A yield that suddenly looks high often means the price fell because the dividend is at risk.
More on Abbott Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.